New hope for fibromyalgia? study tests Two-Drug approach for pain

NCT ID NCT07171320

Recruiting now Symptom relief Sponsor: Beijing Tiantan Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares pregabalin alone versus pregabalin plus desvenlafaxine for treating fibromyalgia, a condition causing widespread pain and fatigue. Researchers will enroll 384 adults with moderate to severe pain that hasn't improved with non-drug treatments. The goal is to see if the combination offers better pain relief without more side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: pregabalin and desvenlafaxine
What this could lead to: If successful, this could offer a more effective pain relief option for people with fibromyalgia who don't get enough help from pregabalin alone.
What could go wrong: This is an early-stage study with no phase designation, so results are uncertain. The combination may not provide significantly better pain relief and could cause more side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FIBROMYALGIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fibromyalgia Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FIBROMYALGIA PAIN PREGABALIN

Contacts and locations

Locations

Beijing Tiantan Hospital, Beijing, Beijing 100070
RECRUITING

Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.